Cybin Inc (CYBN) Prices 24.26M Unit Offering at $0.34/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units
August 1, 2023 9:32 AM EDTTORONTO--(BUSINESS WIRE)-- Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) (Cybin or the Company), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, announced today the pricing of its previously announced overnight marketed public offering (the Offering) of an aggregate of 24,264,706 units of the Company (the Units) at a price of US$0.34 per Unit for aggregate gross proceeds of US$8,250,000.
Each Unit will be comprised of one common share in the capital of the Company (a Common... More
